Sandra Soo-Jin Lee, Ph.D
Publication Details
-
Secondary uses and the governance of de-identified data: lessons from the human genome diversity panel.
BMC Med Ethics. 2011: 16
Recent changes to regulatory guidance in the US and Europe have complicated oversight of secondary research by rendering most uses of de-identified data exempt from human subjects oversight. To identify the implications of such guidelines for harms to participants and communities, this paper explores the secondary uses of one de-identified DNA sample collection with limited oversight: the Human Genome Diversity Project (HGDP)-Centre d'Etude du Polymorphisme Humain, Fondation Jean Dausset (CEPH) Human Genome Diversity Panel.
Help
Trial Administration